| P2093 | author name string | L Rostaing | |
| | N Kamar | |
| | J Izopet | |
| | F Legrand-Abravanel | |
| P2860 | cites work | Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France | Q45373867 |
| | Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances | Q45374976 |
| | Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. | Q45385929 |
| | Hepatitis E virus and chronic hepatitis in organ-transplant recipients | Q45397012 |
| | Chronic hepatitis E with cirrhosis in a kidney-transplant recipient | Q46743789 |
| | Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? | Q50557345 |
| | Brief communication: case reports of ribavirin treatment for chronic hepatitis E. | Q50559518 |
| | Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant | Q56769157 |
| | Hepatitis E in three immunocompromized children in southeastern France | Q57241698 |
| | Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient | Q58097375 |
| | Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? | Q58865446 |
| | A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries | Q33545709 |
| | High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France | Q34008923 |
| | Hepatitis E virus and neurologic disorders | Q34025611 |
| | Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance | Q35067078 |
| | Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity | Q35783632 |
| | Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France | Q35817883 |
| | Hepatitis E virus antibodies in blood donors, France | Q35849075 |
| | Chronic hepatitis E virus infection in liver transplant recipients | Q37126185 |
| | Hepatitis E: an emerging infection in developed countries. | Q37320904 |
| | Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation | Q39164181 |
| | Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay | Q40316613 |
| | Thermal stability of hepatitis E virus | Q40387130 |
| | Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections | Q42016304 |
| | Genotype 3 diversity and quantification of hepatitis E virus RNA. | Q42025099 |
| | Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection | Q42938081 |
| | Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. | Q43117260 |
| | Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation | Q43166681 |
| | Chronic hepatitis E infection in children with liver transplantation | Q43230495 |
| | Hepatitis E virus excretion can be prolonged in patients with hematological malignancies | Q43523115 |
| | Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient | Q44226369 |
| | Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants | Q44790182 |
| | Persistent carriage of hepatitis E virus in patients with HIV infection. | Q45019291 |
| | No reactivation of hepatitis e virus after kidney retransplantation. | Q45361875 |
| | Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection | Q45362400 |
| | Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation | Q45367134 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis E | Q326643 |
| | hepatitis E virus | Q5731737 |
| P304 | page(s) | 2281-2287 | |
| P577 | publication date | 2012-04-30 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Hepatitis E virus: what transplant physicians should know | |
| P478 | volume | 12 | |